MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Drug-induced parkinsonism in Taiwan

    J.J. Lin, K.C. Yueh, A.C. Chen (Nantou, Taiwan)

    Objective: To review drug-induced parkinsonism (DIP) in Taiwan. Background: Drug-induced parkinsonism (DIP) is a frequent etiology of secondary parkinsonism. DIP must always be suspected when…
  • 2016 International Congress

    Incidental finding of drug-induced movement disorder

    G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)

    Objective: Recognizing a drug-induced movement disorder is critical as only stopping using over the counter dopamine-blocking medications such as metoclopramide can reverse or improve clinical…
  • 2016 International Congress

    Three distinct cases of methamphetamine induced movement disorders

    T.A. Clark, J. Kraakevik (Portland, OR, USA)

    Objective: To detail three cases of methamphetamine induced movement disorders with unique clinical phenotypes. Background: MA is an addictive psychostimulant that affects both the central…
  • 2016 International Congress

    Valproate-associated parkinsonism – A critical review of the literature

    F. Brugger, K.P. Bhatia, F.M.C. Besag (St. Gallen, Switzerland)

    Objective: To provide a critical review of the existing literature on valproate-associated parkinsonism and to discuss possible mechanisms. Background: Valproate was first approved as an…
  • 2016 International Congress

    MEK inhibitors have antidyskinetic effects in hemiParkinsonian rats that are associated with critical neurochemical alterations in the striatum

    G. Chen, S. Nie, K. Ma, C. Han, Y. Xu, Z. Zhang, S.M. Papa, X. Cao (Wuhan, People's Republic of China)

    Objective: To examine the effects of MEK inhibitors PD98059 and U0126 on L-DOPA-induced dyskinesia and the induced molecular changes. Background: L-DOPA-induced dyskinesia (LID) represents one…
  • 2016 International Congress

    Persistent drug-induced parkinsonism with normal dopamine transporter imaging

    J.W. Lee, J.Y. Hong, J.S. Oh, I. Lee, J.S. Kim, Y.H. Sohn, P.H. Lee (Wonju, Korea)

    Objective: We investigated whether patients with persistent drug-induced parkinsonism (DIP) showing visually normal dopamine transporter (DAT) imaging had minimal changes in striatal DAT activity using…
  • 2016 International Congress

    A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)

    H.H. Fernandez, S.A. Factor, R.A. Hauser, J. Jimenez-Shahed, W. Ondo, M.S. LeDoux, D. Shprecher, T. Simuni, D. Stamler, K.E. Anderson (Cleveland, OH, USA)

    Objective: To determine the efficacy and safety of deutetrabenazine (DTB) as a treatment for tardive dyskinesia (TD). Background: There is no approved treatment for TD,…
  • 2016 International Congress

    Ciprofloxacin as the cause of syndroma extrapiramidale

    D. Imamovic, N. Subasic, A. Nakicevic, E. Suljic (Sarajevo, Bosnia and Herzegowina)

    Objective: Ciprofloxacin in rare cases can cause paresthesia, dysesthesia, hypoesthesia, tremor, convulsions, dizziness . Background: The patient, 22 years old, comes in the emergency room,…
  • 2016 International Congress

    A survey of movement disorders in a large sample of patients treated with antipsychotic medication

    B. Balint, H. Killaspy, T.R.E. Barnes, N. Freemantle, E. Joyce, D. Martino, K.P. Bhatia (London, United Kingdom)

    Objective: To describe the prevalence and nature of movement disorders (MD) in a large sample of patients treated with antipsychotic medication. Background: Although there are…
  • 2016 International Congress

    Endoscopically-documented pharyngeal dystonia due to neuroleptic use without response to alcohol

    J.P. Squires, W.L. Severt, M.J. Pitman (New York, NY, USA)

    Objective: To review a case of endoscopically-documented pharyngeal dystonia and its response to alcohol. Background: Pharyngeal dystonia is a rare complication of neuroleptic use, resulting…
  • « Previous Page
  • 1
  • …
  • 1820
  • 1821
  • 1822
  • 1823
  • 1824
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley